{"id":"W1983582337","doi":"10.1016/j.pain.2014.03.018","title":"Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: Results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee","year":2014,"lang":"en","type":"article","venue":"Pain","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Regeneron Pharmaceuticals","keywords":"Medicine; Tolerability; Placebo; Osteoarthritis; myalgia; Adverse effect; Discontinuation; Knee pain; Anesthesia; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00340967,0.001136643,0.00224326,0.0006452322,0.0004116559,0.0004618376,0.0006371697,0.001121962,0.00200665],"category_scores_gemma":[0.001446753,0.0005092259,0.00106061,0.0004889309,0.0008934026,0.0007480002,0.000304091,0.0013781,0.0002998004],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003490439,"about_ca_system_score_gemma":0.0009444135,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003756215,"about_ca_topic_score_gemma":0.0009997202,"domain_scores_codex":[0.9993106,0.0004100831,0.00006663168,0.00006187463,0.00008455404,0.00006620893],"domain_scores_gemma":[0.9990408,0.0003046412,0.0002526827,0.00005861362,0.00008475861,0.0002584603],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7731913,0.0431474,0.001863585,0.002602322,0.001590855,0.0002456058,0.0002590806,0.0008190357,0.07923465,0.0001836347,0.0011079,0.09575467],"study_design_scores_gemma":[0.520314,0.4615174,0.009840754,0.00007154582,0.00068723,0.0002009507,0.00004444762,0.0003697706,0.005556765,0.00008097066,0.00128752,0.00002856819],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9829447,0.009507882,0.001605203,0.0002427138,0.0001389773,0.003790747,0.000743064,0.0001269598,0.0008998925],"genre_scores_gemma":[0.9827949,0.007298929,0.003508821,0.0005947893,0.0003818463,0.002978393,0.001176832,0.00002470971,0.001240768],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00340967,"threshold_uncertainty_score":0.01803225,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03481507113406981,"score_gpt":0.2850686812122734,"score_spread":0.2502536100782036,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}